HomeONCO • STO
add
Oncopeptides AB
Previous close
kr 5.02
Day range
kr 5.06 - kr 5.25
Year range
kr 1.04 - kr 6.56
Market cap
1.32B SEK
Avg Volume
5.26M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 19.18M | 135.23% |
Operating expense | 75.02M | -6.76% |
Net income | -62.85M | 14.19% |
Net profit margin | -327.63 | 63.52% |
Earnings per share | — | — |
EBITDA | -55.62M | 23.44% |
Effective tax rate | -0.08% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 70.15M | -81.70% |
Total assets | 136.44M | -69.88% |
Total liabilities | 203.32M | -21.79% |
Total equity | -66.88M | — |
Shares outstanding | 225.76M | — |
Price to book | -16.73 | — |
Return on assets | -90.74% | — |
Return on capital | -142.47% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -62.85M | 14.19% |
Cash from operations | -54.41M | -720.14% |
Cash from investing | — | — |
Cash from financing | 17.96M | -93.34% |
Net change in cash | -37.08M | -113.32% |
Free cash flow | -21.73M | -174.20% |
About
CEO
Founded
2000
Website
Employees
75
